Barbora Liscakova

Barbora Liscakova

Auto-generated profile, based on publicly available information

Barbora Liscakova

Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
AAAndrijana Angelovski
Andrijana Angelovski
HHHana Hribkova
Hana Hribkova
JSJiri Sedmik
Jiri Sedmik
BLBarbora Liscakova
Barbora Liscakova
OSOlga Svecova
Olga Svecova
MBMarketa Bebarova
Marketa Bebarova
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by progressive dementia, brain atrophy, and ultimately death. Using cerebral organoids derived from human-induced pluripotent stem cells (hiPSCs) carrying the familial PSEN1 A246E variant, we investigated the temporal relationship between amyloid-β (Aβ) dysregulation and spontaneous neuronal activity. Multielectrode array recordings from the differentiation day 60 (DD60) to at least DD130 revealed that AD organoids exhibited transient hyperexcitability and hypersynchrony compared with wild-type (WT) controls, followed by a gradual decline in activity. During the enhanced excitability stage, both elevated Aβ42/40 and Aβ aggregate size showed positive correlations with the percentage of active electrodes and the global synchrony index (GSI) in AD organoids. These findings indicate that Aβ dysregulation might contribute to transient network hyperexcitability in early AD. The results also suggest that patient-derived cerebral organoids may serve as a translational model to examine early network dysfunction and inform future investigations of potential Aβ-induced changes in excitability during the preclinical stages of AD.

6 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AAAndrijana Angelovski
Andrijana Angelovski
HHHana Hribkova
Hana Hribkova
JSJiri Sedmik
Jiri Sedmik
BLBarbora Liscakova
Barbora Liscakova
OSOlga Svecova
Olga Svecova
MBMarketa Bebarova
Marketa Bebarova
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by progressive dementia, brain atrophy, and ultimately death. Using cerebral organoids derived from human induced pluripotent stem cells (hiPSCs) carrying the familial PSEN1 A246E variant, we investigated the temporal relationship between amyloid-β (Aβ) dysregulation and spontaneous neuronal activity. Multielectrode array recordings from the differentiation day 60 (DD60) to at least DD130 revealed that AD organoids exhibited transient hyperexcitability and hypersynchrony compared with wild-type (WT) controls, followed by a gradual decline in activity. During the enhanced excitability stage, both elevated Aβ42/40 and Aβ aggregate size showed positive correlations with the percentage of active electrodes and the global synchrony index (GSI) in AD organoids. These findings indicate that Aβ dysregulation might contribute to transient network hyperexcitability in early AD. The results also suggest that patient-derived cerebral organoids may serve as a translational model to examine early network dysfunction and inform future investigations of potential Aβ-induced changes in excitability during the preclinical stages of AD.